Aspiriant Holdings S3’s Novartis NVS Stock Holding History

Aspiriant Holdings S3’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.02M	Buy	13,277 +675	+5%	+$53.6K	0.44%	66
2015 Q3	$1.04M	Sell	12,602 -2,818	-18%	-$251K	0.48%	59
2015 Q2	$1.36M	Buy	15,420 +1,189	+8%	+$109K	0.54%	59
2015 Q1	$1.26M	Sell	14,231 -72	-0.5%	-$6.39K	0.5%	58
2014 Q4	$1.19M	Buy	14,303 +1,126	+9%	+$93.3K	0.49%	63
2014 Q3	$1.11M	Buy	13,177 +882	+7%	+$71.4K	0.45%	62
2014 Q2	$997K	Buy	12,295 +559	+5%	+$44K	0.4%	65
2014 Q1	$894K	Sell	11,736 -434	-4%	-$31.6K	0.38%	71
2013 Q4	$877K	Sell	12,170 -160	-1%	-$11.1K	0.34%	73
2013 Q3	$847K	Buy	12,330 +1,215	+11%	+$80.4K	0.36%	70
2013 Q2	$704K	Buy	+11,115	New	+$723K	0.32%	73

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Aspiriant Holdings S3's NVS Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Novartis (NVS) stake by 5.4% in Q4 2015, buying an estimated $53.6K and bringing the position to 13,277 shares worth $1.02M. The position accounts for 0.44% of the portfolio, ranked #66.

Aspiriant Holdings S3 first reported a position in NVS in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.36M in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Aspiriant Holdings S3 held 13,277 shares of Novartis worth $1.02M as of Q4 2015.
Aspiriant Holdings S3 bought 675 Novartis shares in Q4 2015, an estimated $53.6K.
Novartis made up 0.44% of Aspiriant Holdings S3's portfolio in Q4 2015, its #66 holding.
Aspiriant Holdings S3 first reported a position in Novartis in Q2 2013 and has held it in 11 quarters since.
Aspiriant Holdings S3's Novartis position peaked at $1.36M in Q2 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.